Clinical trial
A Prospective, Multi-Center, Single-Arm Study Assessing the Clinical Use of the CATERPILLAR™ Arterial Embolization Device System for Arterial Embolization in the Peripheral Vasculature (CHRYSALIS)
NCT04090320 is registered in ClinicalTrials.gov with C. R. Bard as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-Center, Single-Arm Study Assessing the Clinical Use of the CATERPILLAR™ Arterial Embolization Device System for Arterial Embolization in the Peripheral Vasculature (CHRYSALIS)
- Lead sponsor
- C. R. Bard
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 25, 2019
- Completion date
- November 4, 2020
- Enrollment
- 20 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
embolization, therapeutic